Boehringer Ingelheim Pharma GmbH & Co. KG
DE-MF-000015595 · Germany · Ingelheim am Rhein
Boehringer Ingelheim Pharma GmbH & Co. KG is registered in the European database on medical devices as a manufacturer, with 8 devices declared. It has a similarly named entry in the FDA register that we have not verified.
What this manufacturer declares
| Class IIb | 7 |
|---|---|
| Class IIa | 1 |
Among these devices, 7 are declared active.
Devices declared under this manufacturer
- HandiHaler
- Respimat
Catalogue references include HH OEFFHI KAMMER AUS PC EU/ROW / 87712, INH RES A5.10.1 R T+O / 87030, INH RES A5.10.1 T+O 60HUB GUMD / 84978, INH RES A5.2 BERO 120HUB GUMD / 84976, INH RES A5.3.1 R SPIRIVA / 87028, INH RES A5.3.1 SPI 60HUB GUMD / 84970.
European nomenclature codes declared: R03010302.
United States market access
| FDA establishment register | Similar name found — unverified |
|---|---|
| Matched entry | Boehringer Ingelheim Pharmaceuticals, Inc. (US) · FDA 1219205 |
| Devices in EUDAMED | 8 |
| Country of registration | Germany |
⚠️ A similar name exists; we do not assert it is the same company — why.
Device-level evidence
| Devices with a numeric GTIN | 8 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.